Data / Form D filings / DMI Life Sciences, Inc.
DMI Life Sciences, Inc.: Form D filings
DMI Life Sciences, Inc., a biotechnology company in Greenwood Village, CO, filed 4 Form D notices with the SEC in 2009. The latest, on May 18, 2009, reports $1.2 million sold of a $2.4 million offering to 8 investors.
Find out what DMI Life Sciences, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 8400 EAST CRESCENT PARKWAY, SUITE 600, Greenwood Village, CO, 80111
- Phone
- (303) 418-1000
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- De
- Year incorporated
- 2009
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1462950
The full lists. Form D filings in Colorado: 1,787 rows, $89.35, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| May 18, 2009 | Amendment | $2,399,999 | $1,209,994 | $1,190,005 | 8 | Apr 16, 2009 | sec.gov |
| Apr 30, 2009 | New notice | $7,350 | $7,350 | $0 | 5 | Apr 17, 2009 | sec.gov |
| Apr 30, 2009 | New notice | $2,399,999 | $999,999 | $1,400,000 | 1 | Apr 16, 2009 | sec.gov |
| Apr 30, 2009 | New notice | Indefinite | $0 | Indefinite | 1 | Apr 16, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Wannell Crook | Executive Officer | |
| James Winkler | Executive Officer | |
| Michael Macaluso | Director | |
| Raphael Bar-Or | Executive Officer | |
| David Bar-Or | Executive Officer, Director | |
| Bruce G. Miller | Executive Officer, Director |
Other biotechnology companies in Colorado that filed recently
- HealthVest Fund V LLC offering · Nov 5, 2026
- GelSana Therapeutics, Inc. $4.4 million · Oct 8, 2026
- Renovare Therapeutics, Inc. $100,000 · Oct 2, 2026
- EnteroTrack, LLC $2 million · Sep 25, 2026
Every Form D from the week of May 18, 2009 · All recent filings in Colorado · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what DMI Life Sciences, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.